imidafenacin
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
AbstractPurpose
We carried out a systematic review and meta-analysis to assess the efficacy and safety of imidafenacin for…
Introduction: Imidafenacin (KRP-197/ONO-8025) is the latest antimuscarinic (AM) developed for the treatment of overactive bladder…
Objective: The aim of this study was to assess the efficacy and safety of long-term treatment with two different antimuscarinics…
Objectives: To investigate the effects of the antimuscarinic agent, propiverine, on the bladder and urethra in rats.
Objective: To evaluate the efficacy of imidafenacin on nocturia and sleep disorder in patients with overactive bladder (OAB…
Imidafenacin (KRP-197) is a novel antimuscarinic agent for overactive bladder treatment. The inhibitory effect of imidafenacin on…
Study design, materials and methods A total 121 patients (54 males; 44.6%, and 67 females; 55.4%), with more than twice of…
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT
The absolute bioavailability of imidafenacin in rats and dogs is 5.6% and 36.1…
Abstract Imidafenacin (CAS 170105-16-5, KRP-197, ONO-8025) has been developed for the treatment of overactive bladder as a new…
Abstract Imidafenacin (CAS 170105-16-5, KRP-197, ONO-8025) is an antagonist for the muscarinic acetylcholine (ACh) receptor…